Tumour Microenvironment Stress Promotes the Development of Drug Resistance

被引:41
|
作者
Seebacher, Nicole A. [1 ]
Krchniakova, Maria [2 ,3 ]
Stacy, Alexandra E. [4 ]
Skoda, Jan [2 ,3 ]
Jansson, Patric J. [4 ,5 ]
机构
[1] Univ Oxford, Dept Oncol, Oxford OX3 9DU, England
[2] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno 62500, Czech Republic
[3] St Annes Univ Hosp, Int Clin Res Ctr, Brno 65691, Czech Republic
[4] Univ Sydney, Sch Med Sci, Fac Med & Hlth, Canc Drug Resistance & Stem Cell Program, Camperdown, NSW 2006, Australia
[5] Univ Sydney, Kolling Inst, Fac Med & Hlth, Bill Walsh Translat Canc Res Lab, St Leonards, NSW 2065, Australia
关键词
tumour microenvironmental stress; drug resistance; reactive oxygen species; cancer stem cells; CANCER-ASSOCIATED FIBROBLASTS; INDUCIBLE FACTOR 1-ALPHA; HUMANIZED MONOCLONAL-ANTIBODY; I DOSE-ESCALATION; CELL LUNG-CANCER; CD4(+) T-CELLS; FACTOR-KAPPA-B; OXIDATIVE STRESS; BREAST-CANCER; UP-REGULATION;
D O I
10.3390/antiox10111801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multi-drug resistance (MDR) is a leading cause of cancer-related death, and it continues to be a major barrier to cancer treatment. The tumour microenvironment (TME) has proven to play an essential role in not only cancer progression and metastasis, but also the development of resistance to chemotherapy. Despite the significant advances in the efficacy of anti-cancer therapies, the development of drug resistance remains a major impediment to therapeutic success. This review highlights the interplay between various factors within the TME that collectively initiate or propagate MDR. The key TME-mediated mechanisms of MDR regulation that will be discussed herein include (1) altered metabolic processing and the reactive oxygen species (ROS)-hypoxia inducible factor (HIF) axis; (2) changes in stromal cells; (3) increased cancer cell survival via autophagy and failure of apoptosis; (4) altered drug delivery, uptake, or efflux and (5) the induction of a cancer stem cell (CSC) phenotype. The review also discusses thought-provoking ideas that may assist in overcoming the TME-induced MDR. We conclude that stressors from the TME and exposure to chemotherapeutic agents are strongly linked to the development of MDR in cancer cells. Therefore, there remains a vast area for potential research to further elicit the interplay between factors existing both within and outside the TME. Elucidating the mechanisms within this network is essential for developing new therapeutic strategies that are less prone to failure due to the development of resistance in cancer cells.
引用
收藏
页数:32
相关论文
共 50 条
  • [21] Development and characterization of a microfluidic model of the tumour microenvironment
    Ayuso, Jose M.
    Virumbrales-Munoz, Maria
    Lacueva, Alodia
    Lanuza, Pilar M.
    Checa-Chavarria, Elisa
    Botella, Pablo
    Fernandez, Eduardo
    Doblare, Manuel
    Allison, Simon J.
    Phillips, Roger M.
    Pardo, Julian
    Fernandez, Luis J.
    Ochoa, Ignacio
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [22] Drug resistance and the solid tumor microenvironment
    Tredan, Olivier
    Galmarini, Carlos M.
    Patel, Krupa
    Tannock, Ian F.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (19) : 1441 - 1454
  • [23] Drug resistance and the microenvironment: nature and nurture
    Morin, PJ
    [J]. DRUG RESISTANCE UPDATES, 2003, 6 (04) : 169 - 172
  • [24] Endoplasmic reticulum stress signals in the tumour and its microenvironment
    Xi Chen
    Juan R. Cubillos-Ruiz
    [J]. Nature Reviews Cancer, 2021, 21 : 71 - 88
  • [25] Endoplasmic reticulum stress signals in the tumour and its microenvironment
    Chen, Xi
    Cubillos-Ruiz, Juan R.
    [J]. NATURE REVIEWS CANCER, 2021, 21 (02) : 71 - 88
  • [26] Reconditioning the Tumour Microenvironment with Immunogene Therapy Suppresses Tumour Development and Progression
    Bourke, M. G.
    Forde, P.
    de Kruijf, M.
    O'Donovan, T.
    Casey, G.
    Soden, D. M.
    O'Sullivan, G. C.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S175 - S176
  • [27] Tumour stem cells and drug resistance
    Dean, M
    Fojo, T
    Bates, S
    [J]. NATURE REVIEWS CANCER, 2005, 5 (04) : 275 - 284
  • [28] Tumour stem cells and drug resistance
    Michael Dean
    Tito Fojo
    Susan Bates
    [J]. Nature Reviews Cancer, 2005, 5 : 275 - 284
  • [29] A Comparative Analysis of Orthotopic and Subcutaneous Pancreatic Tumour Models: Tumour Microenvironment and Drug Delivery
    Fernandez, Jessica Lage
    Arbogen, Sara
    Sadeghinia, Mohammad Javad
    Haram, Margrete
    Snipstad, Sofie
    Torp, Sverre Helge
    Einen, Caroline
    Muhlenpfordt, Melina
    Maardalen, Matilde
    Vikedal, Krister
    Davies, Catharina de Lange
    [J]. CANCERS, 2023, 15 (22)
  • [30] Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
    M D’Incalci
    N Badri
    C M Galmarini
    P Allavena
    [J]. British Journal of Cancer, 2014, 111 : 646 - 650